Question 1

Has Stanford Taylor, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $878,753 in general payments to Stanford Taylor, MD across 59 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Stanford Taylor, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Stanford Taylor, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Genentech, Inc.	39	$804,089
Eyepoint US, Inc.	3	$69,827
US Retina LLC	4	$4,257
Alimera Sciences, Inc.	2	$255
Genentech USA, Inc.	2	$130
Alcon	1	$57
Apellis Pharmaceuticals, Inc.	1	$44
AbbVie(2 entities)	2	$32
Regeneron Healthcare Solutions, Inc.	2	$30
Novartis	1	$16
Optos, Inc.	2	$16

Stanford Taylor, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other retina specialist in Colorado Springs